Abstract
Research activity related to this work was supported, in part, by the I3SNS Program from the Instituto de Salud Carlos III (INT07/030 for BC and INT 07/172 for NS), Madrid, Spain. The ozone therapy device, Ozonosan Alpha-plus®, was provided by Dr. Hansler GmbH (Iffezheim, Germany). Editorial assistance was provided by Dr. Peter R. Turner of t-SciMed (Reus, Spain).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
